Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Trading While We Work -- Ignore unavailable to you. Want to Upgrade?

To: Sergio H who wrote (115)	1/21/2001 7:29:45 PM
From: jef saunders	Respond to of 182

DMTHF (dmx on toronto exchange) is my top holding. friday they announced $50m of equity financing, enough $ to operate through 2006. the first of the drugs they have developed, an arthritis medication "Pennsaid" begins sales in england in march, throughout europe by the end of the year. unlike the top osteoarthritis drugs currently on the market, vioxx and celebrex, this one does not have side effect of death. i expect at least a quadruple this year. sooner if i'm lucky. jeffS